Domingo Chang Dávila
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Domingo Chang Dávila has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Alexandra Nicolau Ferreira
Nephrology Division, Hospital do Rim, Fundação Oswaldo Ramos, São Paulo, Brazil
1 shared publication - Gianna Mastroianni Kirsztajn
Universidade Federal de São Paulo
1 shared publication - Helio Tedesco-Silva
Universidade Federal de Sao Paulo, Brasil
1 shared publication Henrique Machado de Sousa Proença
Nephrology Division, Hospital do Rim, Fundação Oswaldo Ramos, São Paulo, Brazil
1 shared publication- José Osmar Medina-Pestana
Universidade Federal de São Paulo
1 shared publication - Juliana Mansur
Universidade Federal de São Paulo
1 shared publication
Latest Publications
- Open Access
- 28 May 2024
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 10 (6) , e1651
Multiple-target Therapy for Posttransplant Focal Segmental Glomerulosclerosis
Background. There is no consensus on the ideal strategy to treat posttransplant focal segmental glomerulosclerosis. The multiple-target therapy, which consisted of high-dose intravenous cyclosporine, prednisone, and plasmapheresis, showed favorable results. Methods. This single-center, prospective study sought to evaluate the multiple-target therapy in an independent cohort of patients. Results. Thirteen patients with posttransplant focal segmental glomerulosclerosis received multiple-target therapy. Complete remission was achieved in 2 patients (15.4%), and partial remission in another 2 patients (15.4%). Four patients (30.7%) did not show remission, and 5 patients (38%) lost the graft because of posttransplant focal segmental glomerulosclerosis during the 12-mo follow-up. Premature discontinuation of treatment occurred in 10 patients (77%), all associated with infectious adverse events. Cytomegalovirus was the most common complication, and preemptive therapy was used instead of prophylaxis. Conclusions. In this cohort of patients, the efficacy of the multiple-target therapy was poor and limited by the high incidence of infectious adverse events. Export
- 28 May 2024
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 10 (6) , e1651
Open AccessMultiple-target Therapy for Posttransplant Focal Segmental Glomerulosclerosis
Background. There is no consensus on the ideal strategy to treat posttransplant focal segmental glomerulosclerosis. The multiple-target therapy, which consisted of high-dose intravenous cyclosporine, prednisone, and plasmapheresis, showed favorable results. Methods. This single-center, prospective study sought to evaluate the multiple-target therapy in an independent cohort of patients. Results. Thirteen patients with posttransplant focal segmental glomerulosclerosis received multiple-target therapy. Complete remission was achieved in 2 patients (15.4%), and partial remission in another 2 patients (15.4%). Four patients (30.7%) did not show remission, and 5 patients (38%) lost the graft because of posttransplant focal segmental glomerulosclerosis during the 12-mo follow-up. Premature discontinuation of treatment occurred in 10 patients (77%), all associated with infectious adverse events. Cytomegalovirus was the most common complication, and preemptive therapy was used instead of prophylaxis. Conclusions. In this cohort of patients, the efficacy of the multiple-target therapy was poor and limited by the high incidence of infectious adverse events. Export
- Open Access
- 21 July 2016
- Published by Universidad Peruana Cayetano Heredia in Revista Médica Herediana
- Vol. 27 (2) , 111
Actualidad y perspectivas del HLA en el trasplante renal
La introducción de la compatibilidad en los antígenos leucocitarios humanos (HLA) en la selección de los injertos para trasplante renal ha mejorado la sobrevida y el pronóstico del órgano trasplantado, a corto y largo plazo. Sin embargo, recientes observaciones sugieren que la importancia relativa de los HLA ha disminuido en décadas recientes. Posibles explicaciones para este fenómeno incluyen la reciente utilización de terapias inmunosupresoras más potentes, una mayor importancia relativa de antígenos no HLA y factores no inmunológicos.
- 21 July 2016
- Published by Universidad Peruana Cayetano Heredia in Revista Médica Herediana
- Vol. 27 (2) , 111
Open AccessActualidad y perspectivas del HLA en el trasplante renal
La introducción de la compatibilidad en los antígenos leucocitarios humanos (HLA) en la selección de los injertos para trasplante renal ha mejorado la sobrevida y el pronóstico del órgano trasplantado, a corto y largo plazo. Sin embargo, recientes observaciones sugieren que la importancia relativa de los HLA ha disminuido en décadas recientes. Posibles explicaciones para este fenómeno incluyen la reciente utilización de terapias inmunosupresoras más potentes, una mayor importancia relativa de antígenos no HLA y factores no inmunológicos.